Switch to:

GuruFocus Financial Strength Rank measures how strong a company’s financial situation is. It is based on these factors

1. The debt burden that the company has as measured by its Interest coverage (current year).
2. Debt to revenue ratio. The lower, the better
3. Altman Z-score.

A company ranks high with financial strength is likely to withstand any business slowdowns and recessions.

Financial Strength : 6/10

vs
industry
vs
history
Cash to Debt 0.98
WMGI's Cash to Debt is ranked higher than
63% of the 475 Companies
in the Global Medical Devices industry.

( Industry Median: 2.09 vs. WMGI: 0.98 )
WMGI' s 10-Year Cash to Debt Range
Min: 0.06   Max: No Debt
Current: 0.98

Equity to Asset 0.40
WMGI's Equity to Asset is ranked higher than
52% of the 447 Companies
in the Global Medical Devices industry.

( Industry Median: 0.64 vs. WMGI: 0.40 )
WMGI' s 10-Year Equity to Asset Range
Min: -0.4   Max: 0.83
Current: 0.4

-0.4
0.83
F-Score: 2
Z-Score: 1.09
M-Score: -2.59
GuruFocus Profitability Rank ranks how profitable a company is and how likely the company’s business will stay that way. It is based on these factors:

1. Operating Margin
2. Trend of the Operating Margin (5-year average). The company with an uptrend profit margin has a higher rank.
••3. Consistency of the profitability
4. Piotroski F-Score
5. Predictability Rank•

The maximum rank is 10. A rank of 7 or higher means a higher profitability and may stay that way. A rank of 3 or lower indicates that the company has had trouble to make a profit.

Profitability Rank is not directly related to the Financial Strength Rank. But if a company is consistently profitable, its financial strength will be stronger.

Profitability & Growth : 3/10

vs
industry
vs
history
Operating margin (%) -34.01
WMGI's Operating margin (%) is ranked higher than
56% of the 459 Companies
in the Global Medical Devices industry.

( Industry Median: 5.91 vs. WMGI: -34.01 )
WMGI' s 10-Year Operating margin (%) Range
Min: -116.46   Max: 13.22
Current: -34.01

-116.46
13.22
Net-margin (%) -100.33
WMGI's Net-margin (%) is ranked higher than
53% of the 459 Companies
in the Global Medical Devices industry.

( Industry Median: 4.15 vs. WMGI: -100.33 )
WMGI' s 10-Year Net-margin (%) Range
Min: -113.05   Max: 12.48
Current: -100.33

-113.05
12.48
ROE (%) -60.64
WMGI's ROE (%) is ranked higher than
51% of the 445 Companies
in the Global Medical Devices industry.

( Industry Median: 5.20 vs. WMGI: -60.64 )
WMGI' s 10-Year ROE (%) Range
Min: -55.73   Max: 15.55
Current: -60.64

-55.73
15.55
ROA (%) -28.03
WMGI's ROA (%) is ranked higher than
56% of the 475 Companies
in the Global Medical Devices industry.

( Industry Median: 2.77 vs. WMGI: -28.03 )
WMGI' s 10-Year ROA (%) Range
Min: -27.94   Max: 10.66
Current: -28.03

-27.94
10.66
ROC (Joel Greenblatt) (%) -46.66
WMGI's ROC (Joel Greenblatt) (%) is ranked higher than
60% of the 473 Companies
in the Global Medical Devices industry.

( Industry Median: 9.15 vs. WMGI: -46.66 )
WMGI' s 10-Year ROC (Joel Greenblatt) (%) Range
Min: -99.14   Max: 22.84
Current: -46.66

-99.14
22.84
Revenue Growth (%) -26.90
WMGI's Revenue Growth (%) is ranked higher than
51% of the 341 Companies
in the Global Medical Devices industry.

( Industry Median: 5.00 vs. WMGI: -26.90 )
WMGI' s 10-Year Revenue Growth (%) Range
Min: 0   Max: 14.8
Current: -26.9

0
14.8
» WMGI's 10-Y Financials

Financials


Revenue & Net Income
Cash & Debt
Oprt. Cash Flow & Free Cash Flow

» Details

Guru Trades

Q4 2013

WMGI Guru Trades in Q4 2013

Michael Price 774,852 sh (+719.79%)
John Keeley 1,412,920 sh (+5%)
Jim Simons 16,731 sh (unchged)
Mario Gabelli 211,000 sh (unchged)
Ken Fisher 2,469,109 sh (-0.79%)
Steven Cohen 934,520 sh (-7.45%)
Paul Tudor Jones 231,778 sh (-42.06%)
» More
Q1 2014

WMGI Guru Trades in Q1 2014

Paul Tudor Jones 325,000 sh (+40.22%)
Michael Price 783,937 sh (+1.17%)
Mario Gabelli 211,000 sh (unchged)
Jim Simons Sold Out
John Keeley 1,389,061 sh (-1.69%)
Ken Fisher 2,412,479 sh (-2.29%)
Steven Cohen 901,475 sh (-3.54%)
» More
Q2 2014

WMGI Guru Trades in Q2 2014

Columbia Wanger 137,038 sh (New)
Steven Cohen 635,100 sh (unchged)
Mario Gabelli 211,000 sh (unchged)
Michael Price Sold Out
Paul Tudor Jones Sold Out
Ken Fisher 2,389,299 sh (-0.96%)
John Keeley 1,346,781 sh (-3.04%)
» More
Q3 2014

WMGI Guru Trades in Q3 2014

Paul Tudor Jones 300,000 sh (New)
Columbia Wanger 944,900 sh (+589.52%)
Mario Gabelli 211,000 sh (unchged)
John Keeley 1,345,231 sh (-0.12%)
Ken Fisher 2,371,254 sh (-0.76%)
Steven Cohen 316,300 sh (-50.2%)
» More
» Details

Insider Trades

Latest Guru Trades with WMGI

(List those with share number changes of more than 20%, or impact to portfolio more than 0.1%)

GuruDate Trades Impact to Portfolio Price Range * (?) Current Price Change from Average Current Shares
Michael Price 2014-06-30 Sold Out 0.19%$27.35 - $32.41 $ 27.92-6%0
Michael Price 2013-12-31 Add 719.79%0.18%$26.42 - $30.49 $ 27.92-1%774852
Michael Price 2013-09-30 Reduce -54.99%0.41%$23.85 - $28.22 $ 27.927%94518
Michael Price 2013-06-30 Reduce -48.25%0.63%$22.71 - $26.21 $ 27.9215%210000
Joel Greenblatt 2013-06-30 Sold Out 0.04%$22.71 - $26.21 $ 27.9215%0
Joel Greenblatt 2013-03-31 Reduce -34.43%0.02%$20.83 - $24.37 $ 27.9225%29615
Joel Greenblatt 2012-12-31 New Buy0.06%$19.67 - $22.19 $ 27.9234%45167
Joel Greenblatt 2012-09-30 Sold Out 0.05%$18.25 - $22.47 $ 27.9237%0
Ken Fisher 2012-09-30 Add 23.56%0.02%$18.25 - $22.47 $ 27.9237%2139232
Joel Greenblatt 2012-06-30 Add 106.38%0.03%$18.02 - $21.21 $ 27.9241%34444
Joel Greenblatt 2012-03-31 New Buy0.03%$16.06 - $19.56 $ 27.9272%16690
Michael Price 2011-12-31 Add 25.96%0.35%$13.58 - $18.33 $ 27.9274%655000
John Keeley 2011-12-31 Add 1433.33%0.24%$13.58 - $18.33 $ 27.9274%766663
John Keeley 2011-09-30 New Buy0.02%$13.56 - $18.3 $ 27.9281%50000
George Soros 2011-09-30 Sold Out 0.0022%$13.56 - $18.3 $ 27.9281%0
Premium More recent guru trades are included for Premium Members only!!
Premium More recent guru trades are included for USA Subscribe Members only!!
» Interactive Charts

Peter Lynch Chart ( What is Peter Lynch Charts )

Ratios

vs
industry
vs
history
P/B 3.60
WMGI's P/B is ranked higher than
71% of the 511 Companies
in the Global Medical Devices industry.

( Industry Median: 3.88 vs. WMGI: 3.60 )
WMGI' s 10-Year P/B Range
Min: 1.09   Max: 4.8
Current: 3.6

1.09
4.8
P/S 4.80
WMGI's P/S is ranked higher than
64% of the 511 Companies
in the Global Medical Devices industry.

( Industry Median: 3.41 vs. WMGI: 4.80 )
WMGI' s 10-Year P/S Range
Min: 0.96   Max: 6.12
Current: 4.8

0.96
6.12
EV-to-EBIT -14.50
WMGI's EV-to-EBIT is ranked lower than
53% of the 511 Companies
in the Global Medical Devices industry.

( Industry Median: 64.69 vs. WMGI: -14.50 )
WMGI' s 10-Year EV-to-EBIT Range
Min: -250.9   Max: 763.6
Current: -14.5

-250.9
763.6
Current Ratio 3.09
WMGI's Current Ratio is ranked higher than
73% of the 467 Companies
in the Global Medical Devices industry.

( Industry Median: 2.79 vs. WMGI: 3.09 )
WMGI' s 10-Year Current Ratio Range
Min: 1.87   Max: 8.53
Current: 3.09

1.87
8.53
Quick Ratio 2.55
WMGI's Quick Ratio is ranked higher than
76% of the 467 Companies
in the Global Medical Devices industry.

( Industry Median: 2.01 vs. WMGI: 2.55 )
WMGI' s 10-Year Quick Ratio Range
Min: 1.12   Max: 7.78
Current: 2.55

1.12
7.78

Valuation & Return

vs
industry
vs
history
Price/Tangible Book 11.70
WMGI's Price/Tangible Book is ranked higher than
61% of the 511 Companies
in the Global Medical Devices industry.

( Industry Median: 6.71 vs. WMGI: 11.70 )
WMGI' s 10-Year Price/Tangible Book Range
Min: 1.41   Max: 12.68
Current: 11.7

1.41
12.68
Price/DCF (Projected) 12.20
WMGI's Price/DCF (Projected) is ranked higher than
80% of the 511 Companies
in the Global Medical Devices industry.

( Industry Median: 9999.00 vs. WMGI: 12.20 )
WMGI' s 10-Year Price/DCF (Projected) Range
Min: 1.68   Max: 13.29
Current: 12.2

1.68
13.29
Price/Median PS Value 2.00
WMGI's Price/Median PS Value is ranked higher than
57% of the 511 Companies
in the Global Medical Devices industry.

( Industry Median: 1.20 vs. WMGI: 2.00 )
WMGI' s 10-Year Price/Median PS Value Range
Min: 0.42   Max: 2.36
Current: 2

0.42
2.36
Earnings Yield (Greenblatt) -6.80
WMGI's Earnings Yield (Greenblatt) is ranked higher than
57% of the 469 Companies
in the Global Medical Devices industry.

( Industry Median: 2.40 vs. WMGI: -6.80 )
WMGI' s 10-Year Earnings Yield (Greenblatt) Range
Min: -6.8   Max: 8.9
Current: -6.8

-6.8
8.9
Forward Rate of Return (Yacktman) -10.34
WMGI's Forward Rate of Return (Yacktman) is ranked higher than
62% of the 213 Companies
in the Global Medical Devices industry.

( Industry Median: 5.50 vs. WMGI: -10.34 )
WMGI' s 10-Year Forward Rate of Return (Yacktman) Range
Min: -15.7   Max: 18.5
Current: -10.34

-15.7
18.5

Business Description

Industry: Medical Devices » Medical Devices
Compare:MDT, SYK, SMA, ZMH, STJ » details
Traded in other countries:WM3.Germany,
Wright Medical Group, Inc., through Wright Medical Technology, Inc. and other operating subsidiaries, is a specialty orthopaedic company, that provides extremity and biologic solutions that enable clinicians to alleviate pain and restore their patients' lifestyles. The Company provides surgical solutions for the foot and ankle market and markets its products in over 60 countries. Its business includes products that are used in foot and ankle repair, upper extremity products, and biologics products, which are used to replace damaged or diseased bone, to stimulate bone growth and to provide other biological solutions for surgeons and their patients. Extremity hardware includes implants and other devices to replace or reconstruct injured or diseased joints and bones of the foot, ankle, hand, wrist, fingers, toes, elbow and shoulder, which it generally refer to as either foot and ankle or upper extremity products. The Company's manufacturing and warehousing operations are located in Arlington, Tennessee. Outside the U.S., The Company has distribution and administrative facilities in Amsterdam, the Netherlands, and sales and distribution offices in Canada, Australia, and Europe. The Company operates its continuing operations as one reportable segment and offer products in extremity reconstruction and biologics. The Company's products include CHARLOTTE, CLAW II, DARCO, EVOLVE, MICRONAIL, GRAFTJACKET, OSTEOSET. Its competitors include major companies in the orthopaedic and biologics industries, as well as academic institutions and other public and private research organizations that continue to conduct research, seek patent protection and establish arrangements for commercializing products. The Company's products are strictly regulated by the FDA under the Food, Drug, and Cosmetic Act. Some of its products are also regulated by state agencies.
» More Articles for WMGI

Headlines

Articles On GuruFocus.com
Wright Medical Group Inc. Reports Operating Results (10-Q) Oct 29 2010 
Wright Medical Group Inc. Reports Operating Results (10-Q) Aug 03 2010 
Wright Medical Group Inc. (WMGI) Sr. VP & CFO Lance A Berry sells 1,015 Shares May 19 2010 
Wright Medical Group Inc. (WMGI) President and CEO Gary D Henley sells 2,266 Shares May 19 2010 
Wright Medical Group Inc. (WMGI) President and CEO Gary D Henley sells 4,950 Shares May 17 2010 
Wright Medical Group Inc. (WMGI) Sr. VP & CFO Lance A Berry sells 1,260 Shares May 17 2010 
Wright Medical Group Inc. Reports Operating Results (10-Q) May 05 2010 
Wright Medical Group Inc. (WMGI) Exec. VP & CFO John K Bakewell sells 9,249 Shares Dec 04 2009 
Wright Medical Group Inc. Reports Operating Results (10-Q) Oct 30 2009 
Wright Medical Group Inc. Reports Operating Results (10-Q) Aug 04 2009 

More From Other Websites
WRIGHT MEDICAL GROUP INC Files SEC form 8-K, Other Events, Financial Statements and Exhibits Dec 17 2014
APAC Joint Replacement Market to Reach $6.4 Billion by 2020 Dec 10 2014
Zacks Industry Outlook Highlights: Stryker, Smith & Nephew, Wright Medical, Tornier and Medtronic Dec 09 2014
SHAREHOLDER ALERT: Law Firm of Levi & Korsinsky, LLP Notifies Investors of Wright Medical Group,... Dec 01 2014
WRIGHT MEDICAL GROUP INC Financials Nov 29 2014
Robbins Arroyo LLP Is Investigating the Officers and Directors of Wright Medical Group, Inc. (WMGI)... Nov 21 2014
Wright Medical Group, Inc. to Participate in Piper Jaffray Healthcare Conference Nov 18 2014
Wright Medical Group, Inc. to Participate in Piper Jaffray Healthcare Conference Nov 18 2014
SHAREHOLDER ALERT: Brodsky & Smith, LLC Announces Investigation of Wright Medical Group, Inc. in... Nov 11 2014
10-Q for Wright Medical Group, Inc. Nov 09 2014
Wright Medical Posts Wider Q3 Loss; Lowers '14 Outlook Nov 07 2014
Lifshitz & Miller Law Firm Announces Investigation of Aviv REIT, Inc., BTU International, Inc.,... Nov 06 2014
The Wright Medical Group, Inc. Acquisition By Tornier N.V. May Not Be In The Best Interests of WMGI... Nov 06 2014
WRIGHT MEDICAL GROUP INC Files SEC form 10-Q, Quarterly Report Nov 06 2014
Wright Medical misses Street 3Q forecasts Nov 05 2014
Wright Medical misses Street 3Q forecasts Nov 05 2014
Wright Medical Group, Inc. Earnings Call scheduled for 4:30 pm ET today Nov 05 2014
WRIGHT MEDICAL GROUP INC Files SEC form 8-K, Results of Operations and Financial Condition,... Nov 05 2014
Wright Medical Group, Inc. Reports 2014 Third Quarter Financial Results and Updated Guidance Nov 05 2014
Q3 2014 Wright Medical Group Inc Earnings Release - 4:00 pm ET Nov 05 2014

Personalized Checklist

Checklist has been moved to "Checklist" tab.

Get WordPress Plugins for easy affiliate links on Stock Tickers and Guru Names | Earn affiliate commissions by embedding GuruFocus Charts
GuruFocus Affiliate Program: Earn up to $400 per referral. ( Learn More)
Free 7-day Trial
FEEDBACK